Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 19551-19600 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT05937230
Drug-coated Balloons and Drug-eluting Stents in Diabetic Patients
N/A
Active, not recruiting
1,500 participants
Started: Jun 1, 2015 · Completed: Mar 1, 2026
2 conditions
1 sponsor
1 location
NCT02412696
Positive Airway Pressure, Sleep Apnea, and the Placenta (PAP-SAP)
NA
Active, not recruiting
262 participants
Started: Jun 1, 2015 · Completed: May 1, 2025
5 conditions
5 sponsors
1 location
NCT02389595
Selection of a Protective T Cell-based HIV-1/FIV Vaccine
N/A
Active, not recruiting
270 participants
Started: May 31, 2015 · Completed: May 31, 2028
1 condition
1 sponsor
2 locations
NCT02461420
Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome
N/A
Active, not recruiting
205 participants
Started: May 31, 2015 · Completed: Dec 31, 2026
3 conditions
7 sponsors
5 locations
NCT02414269
Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin
PHASE1/PHASE2
Active, not recruiting
113 participants
Started: May 31, 2015 · Completed: Apr 30, 2026
5 conditions
3 sponsors
6 locations
NCT02664935
National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer
PHASE2
Active, not recruiting
423 participants
Started: May 31, 2015 · Completed: Sep 30, 2025
3 conditions
6 sponsors
25 locations
NCT02738788
Airway Changes in Patients Undergoing Elective Surgical Procedures in the Prone and Trendelenburg Positions
N/A
Active, not recruiting
180 participants
Started: May 31, 2015 · Completed: Jul 31, 2026
1 condition
1 sponsor
1 location
NCT02460042
Clinical Post Market Clinical Follow-up (PMCF) on Peripheral Arteries Treated With SeQuent® Please Over The Wire (OTW)
N/A
Active, not recruiting
960 participants
Started: May 31, 2015 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT02461459
Autism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC)
N/A
Active, not recruiting
205 participants
Started: May 31, 2015 · Completed: Dec 31, 2026
3 conditions
7 sponsors
6 locations
NCT02456090
PaTH Clinical Data Research Network (CDRN) Study of Healthy Lifestyles and Health Care
N/A
Active, not recruiting
1,500 participants
Started: May 31, 2015 · Completed: Jul 31, 2030
1 condition
5 sponsors
5 locations
NCT02413970
Inspire® Post-Approval Study / Protocol Number 2014-001
NA
Active, not recruiting
127 participants
Started: May 31, 2015 · Completed: Jun 30, 2025
1 condition
1 sponsor
14 locations
NCT02508454
The Miami Heart Study at Baptist Health South Florida
N/A
Active, not recruiting
4,000 participants
Started: May 31, 2015 · Completed: Sep 30, 2028
1 condition
3 sponsors
1 location
NCT06239142
Understanding Mental Fatigue After Subarachnoid Hemorrhage
N/A
Active, not recruiting
64 participants
Started: May 31, 2015 · Completed: Jun 30, 2024
2 conditions
1 sponsor
0 locations
NCT02252380
ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders
NA
Active, not recruiting
10 participants
Started: May 31, 2015 · Completed: Dec 31, 2026
9 conditions
1 sponsor
2 locations
NCT02450708
Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes
NA
Active, not recruiting
511 participants
Started: May 31, 2015 · Completed: May 31, 2026
1 condition
9 sponsors
10 locations
NCT02413736
Three Versus Five Years of Adjuvant Imatinib as Treatment of Patients With Operable GIST
PHASE3
Active, not recruiting
255 participants
Started: May 31, 2015 · Completed: Jun 30, 2033
1 condition
2 sponsors
1 location
NCT02415413
Carfilzomib in Treatment Patients Under 65 Years With High Risk Smoldering Multiple Myeloma
PHASE2
Active, not recruiting
90 participants
Started: May 31, 2015 · Completed: Jun 30, 2027
1 condition
3 sponsors
16 locations
NCT02455505
Identifying Family Members in Need of Support While Caregiving and After Loss
N/A
Active, not recruiting
52 participants
Started: May 31, 2015 · Completed: May 31, 2027
1 condition
4 sponsors
2 locations
NCT02425904
Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis and LCH-related Disorders
PHASE2
Active, not recruiting
25 participants
Started: May 31, 2015 · Completed: Jan 31, 2026
1 condition
5 sponsors
15 locations
NCT02454543
Impact of Radical Prostatectomy as Primary Treatment in Patients With Prostate Cancer With Limited Bone Metastases
NA
Active, not recruiting
452 participants
Started: May 31, 2015 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT02347722
Biomarkers to Classify Heart Failure
N/A
Active, not recruiting
511 participants
Started: May 31, 2015 · Completed: Dec 31, 2025
1 condition
3 sponsors
1 location
NCT02394834
An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal Cancer
N/A
Active, not recruiting
757 participants
Started: May 29, 2015 · Completed: Mar 31, 2026
1 condition
1 sponsor
151 locations
NCT02311933
Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer
PHASE2
Active, not recruiting
81 participants
Started: May 28, 2015 · Completed: Feb 4, 2026
6 conditions
1 sponsor
563 locations
NCT02393625
Study of Safety and Efficacy of Ceritinib in Combination With Nivolumab in Patients With ALK-positive Non-small Cell Lung Cancer
PHASE1
Active, not recruiting
57 participants
Started: May 27, 2015 · Completed: Apr 9, 2026
1 condition
1 sponsor
12 locations
NCT02400190
The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)
NA
Active, not recruiting
202 participants
Started: May 27, 2015 · Completed: May 31, 2026
1 condition
12 sponsors
13 locations
NCT02257528
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
PHASE2
Active, not recruiting
26 participants
Started: May 18, 2015 · Completed: Mar 17, 2026
6 conditions
2 sponsors
333 locations
NCT02208362
Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma
PHASE1
Active, not recruiting
65 participants
Started: May 18, 2015 · Completed: Jun 8, 2026
8 conditions
3 sponsors
1 location
NCT02314169
Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer
PHASE2
Active, not recruiting
37 participants
Started: May 13, 2015 · Completed: Mar 21, 2026
3 conditions
1 sponsor
56 locations
NCT02652078
Shockwave Therapy in Lower Limb Intermittent Calf Claudication
NA
Active, not recruiting
138 participants
Started: May 11, 2015 · Completed: Feb 1, 2030
1 condition
2 sponsors
1 location
NCT02438722
S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer
PHASE2/PHASE3
Active, not recruiting
174 participants
Started: May 7, 2015 · Completed: Nov 15, 2025
2 conditions
2 sponsors
638 locations
NCT04254731
Effects of Switching From Racemic Methadone to R-methadone on QTc Intervals
PHASE4
Active, not recruiting
10 participants
Started: May 7, 2015 · Completed: Jul 30, 2024
3 conditions
1 sponsor
3 locations
NCT02411448
A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Previously Untreated Participants With EGFR Mutation-Positive Metastatic NSCLC (RELAY)
PHASE3
Active, not recruiting
545 participants
Started: May 6, 2015 · Completed: Dec 31, 2025
1 condition
1 sponsor
106 locations
NCT02449421
Sustaining and Improving Clinicians' Use of Evidence-Based Psychotherapy (EBP) for PTSD
NA
Active, not recruiting
90 participants
Started: May 6, 2015 · Completed: Jun 30, 2024
1 condition
6 sponsors
3 locations
NCT02446249
Safety of a Single Administration of AAV2hAQP1, an Adeno-Associated Viral Vector Encoding Human Aquaporin-1 to One Parotid Salivary Gland in People With Irradiation-Induced Parotid Salivary Hypofunction
PHASE1
Active, not recruiting
17 participants
Started: May 4, 2015 · Completed: Jul 31, 2026
3 conditions
2 sponsors
1 location
NCT02369406
Early Infant HIV Treatment in Botswana
PHASE2/PHASE3
Active, not recruiting
67 participants
Started: May 4, 2015 · Completed: Jun 30, 2029
2 conditions
5 sponsors
1 location
NCT02518269
A 3-Arm Study on G7 Acetabular Cup With Echo BiMetric Stem in Total Hip Arthroplasty
NA
Active, not recruiting
360 participants
Started: May 4, 2015 · Completed: Nov 30, 2030
3 conditions
1 sponsor
5 locations
NCT02455557
SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
PHASE2
Active, not recruiting
66 participants
Started: May 4, 2015 · Completed: Nov 30, 2025
2 conditions
1 sponsor
5 locations
NCT04883476
Chronic Low Back Pain and Neck Pain Prospective Study
N/A
Active, not recruiting
800 participants
Started: May 1, 2015 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT02922296
Glucose Metabolism in Sickle Cell Disease
N/A
Active, not recruiting
75 participants
Started: May 1, 2015 · Completed: Aug 1, 2026
2 conditions
1 sponsor
1 location
NCT02404402
LED Treatment to Improve Cognition and Promote Recovery in TBI
NA
Active, not recruiting
8 participants
Started: May 1, 2015 · Completed: Oct 31, 2027
2 conditions
1 sponsor
1 location
NCT03962127
MIDNOR-STROKE- a Long Term Follow-up Study of Patients With First Ever Ischemic Stroke in Central Norway
N/A
Active, not recruiting
800 participants
Started: May 1, 2015 · Completed: Aug 31, 2026
9 conditions
3 sponsors
8 locations
NCT02509520
Assessing The Effects of Exercise, Protein, and Electric Stimulation On Intensive Care Unit Patients Outcomes
NA
Active, not recruiting
60 participants
Started: May 1, 2015 · Completed: May 1, 2026
3 conditions
1 sponsor
1 location
NCT02724488
Selection Pressure and Evolution Induced by Immune Checkpoint Inhibitors and Other Immunologic Therapies
N/A
Active, not recruiting
14 participants
Started: Apr 30, 2015 · Completed: Jul 31, 2026
2 conditions
2 sponsors
0 locations
NCT02425566
Role of Sympathetic Activity and Splanchnic Capacitance in Hypertension
PHASE1
Active, not recruiting
12 participants
Started: Apr 30, 2015 · Completed: Aug 31, 2026
1 condition
1 sponsor
1 location
NCT02322840
Transcatheter Mitral Valve Replacement System (TMVR) Pilot Study and The Early Feasibility Study of the TMVR Transseptal System
NA
Active, not recruiting
33 participants
Started: Apr 30, 2015 · Completed: Dec 31, 2028
1 condition
2 sponsors
17 locations
NCT02426307
Subclinical Aortic Valve Bioprosthesis Thrombosis Assessed With 4D CT
N/A
Active, not recruiting
274 participants
Started: Apr 30, 2015 · Completed: Apr 30, 2030
1 condition
2 sponsors
1 location
NCT02088645
177Lu-PP-F11N for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer.
PHASE1
Active, not recruiting
24 participants
Started: Apr 30, 2015 · Completed: Jun 30, 2027
4 conditions
5 sponsors
1 location
NCT02106572
Therapeutic Instillation of Mistletoe
PHASE3
Active, not recruiting
548 participants
Started: Apr 30, 2015 · Completed: Dec 31, 2028
1 condition
1 sponsor
5 locations
NCT02436993
Phase II Breast Ca Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab or Bevacizumab
PHASE2
Active, not recruiting
120 participants
Started: Apr 30, 2015 · Completed: Dec 31, 2036
1 condition
1 sponsor
1 location
NCT02369731
Registry of Translarna (Ataluren) in Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD)
N/A
Active, not recruiting
316 participants
Started: Apr 30, 2015 · Completed: May 30, 2025
1 condition
3 sponsors
71 locations
Previous
1
More pages
389
390
391
392
393
394
395
More pages
431
Next